APO Research
Talk to an analyst

APO RESEARCH · REPORT

GERD

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global GERD Market Outlook and Growth Opportunities 2026

22 December 2025197 pages

Choose your research edition.

Industry ResearchGERD Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal GERD Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal GERD Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GERD Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal GERD Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global GERD market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for GERD is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GERD is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GERD is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the GERD market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the GERD market include Takeda, Eisai, Johnson & Johnson, GlaxoSmithKline and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GERD market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GERD and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GERD sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GERD market size, projected growth trends, production technologies, key applications, and end-use industries.

GERD Segment by Company

Takeda

Eisai

Johnson & Johnson

GlaxoSmithKline

AstraZeneca

GERD Segment by Type

CAM

H2 Receptor Antagonists

Prokinetics

Antacids

Proton Pumps Inhibitors

GERD Segment by Application

Hospital Pharmacy

Drug Stores

Supermarkets

General Stores

GERD Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global GERD status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions GERD market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GERD significant trends, drivers, influence factors in global and regions.

6. To analyze GERD competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GERD market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GERD and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GERD.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GERD market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GERD industry.

Chapter 3: Detailed analysis of GERD manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of GERD in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of GERD in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GERD Industry Trends Table 2. GERD Industry Drivers Table 3. GERD Industry Opportunities and Challenges Table 4. GERD Industry Restraints Table 5. Global GERD Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GERD Revenue Share by Company (2021-2026) Table 7. Global GERD Sales Volume by Company (k units) & (2021-2026) Table 8. Global GERD Sales Volume Share by Company (2021-2026) Table 9. Global GERD Average Price (US$/unit) of Company (2021-2026) Table 10. Global GERD Company Ranking, (2024-2026) & (USD Million) Table 11. Global GERD Key Company Manufacturing Base & Headquarters Table 12. Global GERD Company, Product Type & Application Table 13. Global GERD Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global GERD by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of CAM Table 18. Significant Companies of H2 Receptor Antagonists Table 19. Significant Companies of Prokinetics Table 20. Significant Companies of Antacids Table 21. Significant Companies of Proton Pumps Inhibitors Table 22. Global GERD Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global GERD Sales Volume by Type (2021-2026) & (k units) Table 24. Global GERD Sales Volume by Type (2027-2032) & (k units) Table 25. Global GERD Sales Volume Share by Type (2021-2026) Table 26. Global GERD Sales Volume Share by Type (2027-2032) Table 27. Global GERD Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global GERD Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global GERD Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global GERD Sales Value Share by Type (2021-2026) Table 31. Global GERD Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Pharmacy Table 33. Significant Companies of Drug Stores Table 34. Significant Companies of Supermarkets Table 35. Significant Companies of General Stores Table 36. Global GERD Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global GERD Sales Volume by Application (2021-2026) & (k units) Table 38. Global GERD Sales Volume by Application (2027-2032) & (k units) Table 39. Global GERD Sales Volume Share by Application (2021-2026) Table 40. Global GERD Sales Volume Share by Application (2027-2032) Table 41. Global GERD Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global GERD Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global GERD Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global GERD Sales Value Share by Application (2021-2026) Table 45. Global GERD Sales Value Share by Application (2027-2032) Table 46. Global GERD Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global GERD Sales by Region (2021-2026) & (k units) Table 48. Global GERD Sales Market Share by Region (2021-2026) Table 49. Global GERD Sales by Region (2027-2032) & (k units) Table 50. Global GERD Sales Market Share by Region (2027-2032) Table 51. Global GERD Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global GERD Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global GERD Sales Value Share by Region (2021-2026) Table 54. Global GERD Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global GERD Sales Value Share by Region (2027-2032) Table 56. Global GERD Market Average Price (US$/unit) by Region (2021-2026) Table 57. Global GERD Market Average Price (US$/unit) by Region (2027-2032) Table 58. Global GERD Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global GERD Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global GERD Sales by Country (2021-2026) & (k units) Table 61. Global GERD Sales Market Share by Country (2021-2026) Table 62. Global GERD Sales by Country (2027-2032) & (k units) Table 63. Global GERD Sales Market Share by Country (2027-2032) Table 64. Global GERD Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global GERD Sales Value Market Share by Country (2021-2026) Table 66. Global GERD Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global GERD Sales Value Market Share by Country (2027-2032) Table 68. Takeda Company Information Table 69. Takeda Business Overview Table 70. Takeda GERD Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Takeda GERD Product Portfolio Table 72. Takeda Recent Development Table 73. Eisai Company Information Table 74. Eisai Business Overview Table 75. Eisai GERD Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Eisai GERD Product Portfolio Table 77. Eisai Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson GERD Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Johnson & Johnson GERD Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline GERD Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline GERD Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. AstraZeneca Company Information Table 89. AstraZeneca Business Overview Table 90. AstraZeneca GERD Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. AstraZeneca GERD Product Portfolio Table 92. AstraZeneca Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. GERD Distributors List Table 96. GERD Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. GERD Product Image Figure 2. Global GERD Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GERD Sales Value (2021-2032) & (US$ Million) Figure 4. Global GERD Sales (2021-2032) & (k units) Figure 5. Global GERD Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global GERD Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. CAM Image Figure 10. H2 Receptor Antagonists Image Figure 11. Prokinetics Image Figure 12. Antacids Image Figure 13. Proton Pumps Inhibitors Image Figure 14. Global GERD Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global GERD Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global GERD Sales Volume Share by Type (2021-2032) Figure 17. Global GERD Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global GERD Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global GERD Sales Value Share by Type (2021-2032) Figure 20. Hospital Pharmacy Image Figure 21. Drug Stores Image Figure 22. Supermarkets Image Figure 23. General Stores Image Figure 24. Global GERD Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global GERD Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global GERD Sales Volume Share by Application (2021-2032) Figure 27. Global GERD Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global GERD Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global GERD Sales Value Share by Application (2021-2032) Figure 30. Global GERD Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global GERD Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global GERD Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global GERD Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America GERD Sales Value (2021-2032) & (US$ Million) Figure 35. North America GERD Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe GERD Sales Value (2021-2032) & (US$ Million) Figure 37. Europe GERD Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific GERD Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific GERD Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America GERD Sales Value (2021-2032) & (US$ Million) Figure 41. South America GERD Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa GERD Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa GERD Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt GERD Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt GERD Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt GERD Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. GERD Value Chain Figure 129. Manufacturing Cost Structure Figure 130. GERD Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • CAM
  • H2 Receptor Antagonists
  • Prokinetics
  • Antacids
  • Proton Pumps Inhibitors
Applications
  • Hospital Pharmacy
  • Drug Stores
  • Supermarkets
  • General Stores
Companies covered
  • Takeda
  • Eisai
  • Johnson & Johnson
  • GlaxoSmithKline
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GERD Sales Value (2021-2032)
  4. 1.2.2 Global GERD Sales Volume (2021-2032)
  5. 1.2.3 Global GERD Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 GERD Market Dynamics
  1. 2.1 GERD Industry Trends
  2. 2.2 GERD Industry Drivers
  3. 2.3 GERD Industry Opportunities and Challenges
  4. 2.4 GERD Industry Restraints
3 GERD Market by Company
  1. 3.1 Global GERD Company Revenue Ranking in 2025
  2. 3.2 Global GERD Revenue by Company (2021-2026)
  3. 3.3 Global GERD Sales Volume by Company (2021-2026)
  4. 3.4 Global GERD Average Price by Company (2021-2026)
  5. 3.5 Global GERD Company Ranking (2024-2026)
  6. 3.6 Global GERD Company Manufacturing Base and Headquarters
  7. 3.7 Global GERD Company Product Type and Application
  8. 3.8 Global GERD Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global GERD Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 GERD Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 GERD Market by Type
  1. 4.1 GERD Type Introduction
  2. 4.1.1 CAM
  3. 4.1.2 H2 Receptor Antagonists
  4. 4.1.3 Prokinetics
  5. 4.1.4 Antacids
  6. 4.1.5 Proton Pumps Inhibitors
  7. 4.2 Global GERD Sales Volume by Type
  8. 4.2.1 Global GERD Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global GERD Sales Volume by Type (2021-2032)
  10. 4.2.3 Global GERD Sales Volume Share by Type (2021-2032)
  11. 4.3 Global GERD Sales Value by Type
  12. 4.3.1 Global GERD Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global GERD Sales Value by Type (2021-2032)
  14. 4.3.3 Global GERD Sales Value Share by Type (2021-2032)
5 GERD Market by Application
  1. 5.1 GERD Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Drug Stores
  4. 5.1.3 Supermarkets
  5. 5.1.4 General Stores
  6. 5.2 Global GERD Sales Volume by Application
  7. 5.2.1 Global GERD Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global GERD Sales Volume by Application (2021-2032)
  9. 5.2.3 Global GERD Sales Volume Share by Application (2021-2032)
  10. 5.3 Global GERD Sales Value by Application
  11. 5.3.1 Global GERD Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global GERD Sales Value by Application (2021-2032)
  13. 5.3.3 Global GERD Sales Value Share by Application (2021-2032)
6 GERD Regional Sales and Value Analysis
  1. 6.1 Global GERD Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GERD Sales by Region (2021-2032)
  3. 6.2.1 Global GERD Sales by Region: 2021-2026
  4. 6.2.2 Global GERD Sales by Region (2027-2032)
  5. 6.3 Global GERD Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global GERD Sales Value by Region (2021-2032)
  7. 6.4.1 Global GERD Sales Value by Region: 2021-2026
  8. 6.4.2 Global GERD Sales Value by Region (2027-2032)
  9. 6.5 Global GERD Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America GERD Sales Value (2021-2032)
  12. 6.6.2 North America GERD Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe GERD Sales Value (2021-2032)
  15. 6.7.2 Europe GERD Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific GERD Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific GERD Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America GERD Sales Value (2021-2032)
  21. 6.9.2 South America GERD Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa GERD Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa GERD Sales Value Share by Country, 2025 VS 2032
7 GERD Country-level Sales and Value Analysis
  1. 7.1 Global GERD Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GERD Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global GERD Sales by Country (2021-2032)
  4. 7.3.1 Global GERD Sales by Country (2021-2026)
  5. 7.3.2 Global GERD Sales by Country (2027-2032)
  6. 7.4 Global GERD Sales Value by Country (2021-2032)
  7. 7.4.1 Global GERD Sales Value by Country (2021-2026)
  8. 7.4.2 Global GERD Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA GERD Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA GERD Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA GERD Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada GERD Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada GERD Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada GERD Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico GERD Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico GERD Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico GERD Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany GERD Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany GERD Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany GERD Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France GERD Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France GERD Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France GERD Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. GERD Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. GERD Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. GERD Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy GERD Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy GERD Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy GERD Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain GERD Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain GERD Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain GERD Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia GERD Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia GERD Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia GERD Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands GERD Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands GERD Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands GERD Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries GERD Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries GERD Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries GERD Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China GERD Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China GERD Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China GERD Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan GERD Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan GERD Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan GERD Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea GERD Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea GERD Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea GERD Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India GERD Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India GERD Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India GERD Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia GERD Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia GERD Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia GERD Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia GERD Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia GERD Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia GERD Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil GERD Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil GERD Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil GERD Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina GERD Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina GERD Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina GERD Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile GERD Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile GERD Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile GERD Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia GERD Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia GERD Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia GERD Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru GERD Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru GERD Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru GERD Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia GERD Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia GERD Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia GERD Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel GERD Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel GERD Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel GERD Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE GERD Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE GERD Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE GERD Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey GERD Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey GERD Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey GERD Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran GERD Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran GERD Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran GERD Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt GERD Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt GERD Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt GERD Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda GERD Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda GERD Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Eisai
  8. 8.2.1 Eisai Company Information
  9. 8.2.2 Eisai Business Overview
  10. 8.2.3 Eisai GERD Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eisai GERD Product Portfolio
  12. 8.2.5 Eisai Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson GERD Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson GERD Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline GERD Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline GERD Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca GERD Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca GERD Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GERD Value Chain Analysis
  2. 9.1.1 GERD Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GERD Sales Mode & Process
  6. 9.2 GERD Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GERD Distributors
  9. 9.2.3 GERD Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst